A Brain-Targeted DNA Delivery Nanocarrier Modulator for Synergistic Therapy of Parkinson’s Disease
ACS Applied Materials & Interfaces · 15.07.2026 · 18 (27) · 37604-37616
DOI: 10.1021/acsami.6c06170 ↗Kurz gefasst
Fachartikel in der Zeitschrift ACS Applied Materials & Interfaces, online erschienen am 02.07.2026. Verfasst von Yuxue Cheng und 9 weiteren Autor:innen. Beteiligte Einrichtung: School of Life Sciences, South China Normal University, Guangzhou 510631, China. Hauptthemen laut MEDLINE: Parkinson Disease, Nanoparticles, DNA, Brain. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 45 Literaturangaben. Gefördert von: Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme, National Natural Science Foundation of China (NSFC).
Abstract (Originalsprache)
The pathological characteristics of Parkinson's Disease (PD) are multifactorial, encompassing the aggregation of α-synuclein, mitochondrial dysfunction, and oxidative stress, necessitating the adoption of multitarget therapeutic strategies. In this study, a borneol-modified carboxymethyl chitosan nanoparticle system (BC/P/HCR NPs) was developed, aiming to codeliver curcumin, rosmarinic acid, and plasmid DNA (pDNA) targeting the SNCA gene for synergistic therapeutic intervention in PD. Borneol is capable of enhancing the permeability of the blood-brain barrier (BBB), while carboxymethyl chitosan contributes to improving the solubility of curcumin and preventing premature drug release. In a C57BL/6 mouse model of PD, BC/P/HCR NPs demonstrated enhanced penetration through the BBB, effectively alleviating motor dysfunction and reducing neuronal damage by downregulating the expression of α-synuclein, restoring mitochondrial function, and mitigating oxidative stress. These findings underscore the potential of BC/P/HCR NPs as a multifunctional nanotherapeutic platform for addressing the complex pathological features of PD.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Life Sciences, South China Normal University, Guangzhou 510631, China.
- South China Normal University-Panyu Central Hospital Joint Laboratory of Translational Medical Research, Panyu Central Hospital, Guangzhou 511400, China.
ORCID-Profile: Yan-Qing Guan
Förderung
- Guangdong Province Universities and Colleges Pearl River Scholar Funded Scheme
- National Natural Science Foundation of China (NSFC)
Zitieren
APA
Cheng, Y., Zhai, L., Wang, H., Liao, B., Che, J., Ma, K., Huang, G., Pan, S., Yang, H., & Guan, Y. Q. (2026). A Brain-Targeted DNA Delivery Nanocarrier Modulator for Synergistic Therapy of Parkinson’s Disease. ACS Applied Materials & Interfaces, 18(27), 37604-37616. https://doi.org/10.1021/acsami.6c06170
Vancouver
Cheng Y, Zhai L, Wang H, Liao B, Che J, Ma K, et al. A Brain-Targeted DNA Delivery Nanocarrier Modulator for Synergistic Therapy of Parkinson’s Disease. ACS Applied Materials & Interfaces. 2026;18(27):37604-37616. doi:10.1021/acsami.6c06170
BibTeX
@article{Cheng2026,
author = {Cheng, Yuxue and Zhai, Limin and Wang, Haoyuan and Liao, Beining and Che, Jingfeng and Ma, Kuo and Huang, Guowei and Pan, Shengjun and Yang, Hao and Guan, Yan-Qing},
title = {A Brain-Targeted DNA Delivery Nanocarrier Modulator for Synergistic Therapy of Parkinson’s Disease},
journal = {ACS Applied Materials & Interfaces},
year = {2026},
volume = {18},
number = {27},
pages = {37604--37616},
doi = {10.1021/acsami.6c06170}
}
EUVIMED